153 related articles for article (PubMed ID: 10410668)
1. [Cancer of the liver, pancreas, gallbladder, and bile duct].
Furue H
Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():139-44. PubMed ID: 10410668
[TBL] [Abstract][Full Text] [Related]
2. [Which way ahead? Carcinoma of the exocrine pancreas, the gallbladder and the bile ducts--nonsurgical therapy in the locally advanced and in the metastasized stage].
Orth HB; Stalder GA; Landmann C; Herrmann R
Schweiz Med Wochenschr; 1994 May; 124(20):837-45. PubMed ID: 7516091
[TBL] [Abstract][Full Text] [Related]
3. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
[TBL] [Abstract][Full Text] [Related]
4. A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization.
Homma H; Doi T; Mezawa S; Takada K; Kukitsu T; Oku T; Akiyama T; Kusakabe T; Miyanishi K; Niitsu Y
Cancer; 2000 Jul; 89(2):303-13. PubMed ID: 10918160
[TBL] [Abstract][Full Text] [Related]
5. [Primary liver and bile duct tumors: approach to conservative therapy].
Henne-Bruns D; Marks HG
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():343-7. PubMed ID: 9931637
[TBL] [Abstract][Full Text] [Related]
6. [Transcatheter arterial chemo-embolization combined with CT-guided percutaneous intratumoral injection of lipiodol-ethanol for the treatment of primary hepatocellular carcinoma].
Wu P; Li L; Zhang Y
Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):391-3. PubMed ID: 10921042
[TBL] [Abstract][Full Text] [Related]
7. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].
Shi Z; Guo Y; Liu D
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839
[TBL] [Abstract][Full Text] [Related]
10. Management of esophageal, gastric, pancreatic, and hepatobiliary neoplasms.
Bleiberg H
Curr Opin Oncol; 1991 Aug; 3(4):737-44. PubMed ID: 1657205
[TBL] [Abstract][Full Text] [Related]
11. [Palliative therapy in cholangio- and gallbladder carcinoma].
Klebl F; Endlicher E; Kullmann F
Z Gastroenterol; 2006 Jul; 44(7):587-98. PubMed ID: 16823700
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
14. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H
J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
[TBL] [Abstract][Full Text] [Related]
15. [Selection of a method for treating cancer of the pancreaticoduodenal region].
Futorian ES; Shubin BM
Vopr Onkol; 1971; 17(6):90-7. PubMed ID: 4109626
[No Abstract] [Full Text] [Related]
16. [Transcatheter arterial embolization therapy and local ablation].
Tanaka S; Hamuro M; Nishida N; Kaminou T; Matsuoka T; Nakamura K; Yamada R
Nihon Rinsho; 2001 Oct; 59 Suppl 6():721-5. PubMed ID: 11762045
[No Abstract] [Full Text] [Related]
17. [A new development in interventional radiology for hepatocellular carcinoma].
Kumada T; Sone Y; Hasegawa T; Ishiguro H
Gan To Kagaku Ryoho; 2001 Dec; 28(13):1968-74. PubMed ID: 11791376
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
19. Liver-directed treatment modalities for primary and secondary hepatic tumors.
Yamane B; Weber S
Surg Clin North Am; 2009 Feb; 89(1):97-113, ix. PubMed ID: 19186233
[TBL] [Abstract][Full Text] [Related]
20. [Change of approach in tumor therapy: role of percutaneous and vascular ablation in the treatment of advanced primary and secondary liver cancer].
Engloner L
Orv Hetil; 2002 Nov; 143(45):2523-30. PubMed ID: 12501558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
